1 – 32 of 32
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Unreported incidental pulmonary embolism in patients with cancer : Radiologic natural history and risk of recurrent venous thromboembolism and death
(
- Contribution to journal › Article
-
Mark
Rare-variant collapsing analyses reveal novel risk genes for arterial and venous cardiovascular diseases in the UK biobank
(
- Contribution to journal › Letter
- 2021
-
Mark
Sex differences in Lemierre syndrome : Individual patient-level analysis
(
- Contribution to journal › Letter
-
Mark
Translating the success of prophylaxis in haemophilia to von Willebrand disease
(
- Contribution to journal › Scientific review
-
Mark
Quality and predictors of oral anticoagulation therapy with vitamin K antagonists in adult congenital heart disease : TTR and INR variability
(
- Contribution to journal › Letter
- 2020
-
Mark
Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and rivaroxaban in atrial fibrillation
(
- Contribution to journal › Article
- 2019
-
Mark
The role of von Willebrand factor in acute type A aortic dissection and aortic surgery
(
- Contribution to journal › Article
-
Mark
Hypertension and cardiovascular diseases in Swedish persons with haemophilia — A longitudinal registry study
(
- Contribution to journal › Article
- 2018
-
Mark
Prophylactic doses of low-molecular weight heparin as periprocedural bridging therapy in mechanical heart valve patients
(
- Contribution to journal › Article
-
Mark
Interaction of factor VII activating protease (FSAP) with neutrophil extracellular traps (NETs)
(
- Contribution to journal › Article
-
Mark
Current evidence of oral anticoagulant reversal : A systematic review
(
- Contribution to journal › Scientific review
-
Mark
Increased platelet activation occurs in cystic fibrosis patients and correlates to clinical status
(
- Contribution to journal › Article
-
Mark
Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation
(
- Contribution to journal › Article
-
Mark
Prevalence and in silico analysis of missense mutations in the PROS1 gene in the Swedish population : The SweGen dataset
(
- Contribution to journal › Letter
-
Mark
Pretreatment with ticagrelor may offset additional inhibition of platelet and coagulation activation with bivalirudin compared to heparin during primary percutaneous coronary intervention
(
- Contribution to journal › Article
- 2017
-
Mark
A sibling based design to quantify genetic and shared environmental effects of venous thromboembolism in Sweden
(
- Contribution to journal › Article
-
Mark
Seasonal variation of pulmonary embolism and age dependence
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Venous thrombosis in children and adolescents with Hodgkin lymphoma in Sweden
(
- Contribution to journal › Article
-
Mark
Ischemic stroke rates decline in patients with atrial fibrillation as anticoagulants uptake improves : A Swedish cohort study
(
- Contribution to journal › Article
-
Mark
Comparison of citrated and fresh whole blood for viscoelastic coagulation testing during elective neurosurgery
(
- Contribution to journal › Article
- 2016
-
Mark
Current view and outcome of ITI therapy : A change over time?
(
- Contribution to journal › Article
-
Mark
Does the intensity and quality of treatment and not only the factor VIII level influence global hemostasis in patients with hemophilia A?
(
- Contribution to journal › Letter
- 1999
-
Mark
The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism PlA2 in patients with central retinal vein occlusion
(
- Contribution to journal › Article
- 1997
-
Mark
Activated protein C resistance caused by a common factor V mutation has a single origin
(
- Contribution to journal › Article
- 1996
-
Mark
High prevalence of the FVR506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis.
(
- Contribution to journal › Letter
-
Mark
Pharmacokinetics and delayed experimental anti-thrombotic effect of two domain non-glycosylated tissue factor pathway inhibitor
(
- Contribution to journal › Article
- 1995
-
Mark
Treatment with recombinant human erythropoietin induces a moderate rise in hematocrit and thrombin antithrombin in healthy subjects
(
- Contribution to journal › Article
-
Mark
Effects of hemodialysis and longterm erythropoietin treatment on protein C, and on free and total protein S
(
- Contribution to journal › Article
- 1993
-
Mark
Tissue factor pathway inhibitor (TFPI) and its response to heparin in patients with spontaneous deep vein thrombosis
(
- Contribution to journal › Article
- 1983
-
Mark
The effects of plasmin and protein Ca on factor VIII:C and VIII:CAg
(
- Contribution to journal › Article
- 1981
-
Mark
F VIII:CAg in Haemophilia A. A comparison between IRMA:s using haemophilic and spontaneous antibodies
(
- Contribution to journal › Article
- 1978
-
Mark
Purification of F.VIII:C by antigen-antibody chromatography
(
- Contribution to journal › Article